Thomas Gad, President and Chairman

YMAB 634,000 shares

The estimated Net Worth of Thomas Gad is at least $24,821,670.60. Thomas Gad owns over 634,000 units of Y-mAbs Therapeutics, Inc. stock worth over $24,821,670.60.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
15th October 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale10b5-1 trading plan634,000$39.15$156,603.60$24,821,670.60
1st October 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale10b5-1 trading plan638,000$38.88$155,524.40$24,806,141.80
15th September 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale10b5-1 trading plan642,000$40.81$163,224.80$26,197,580.40
11th April 2019YMAB - Y-mAbs Therapeutics, Inc.150,000Open or private sale940,000$25.80$3,870,000.00$24,252,000.00
9th April 2019YMAB - Y-mAbs Therapeutics, Inc.800Open or private sale1,090,000$26.93$21,545.28$29,355,444.00
9th April 2019YMAB - Y-mAbs Therapeutics, Inc.99,200Open or private sale1,090,800$26.02$2,581,184.00$28,382,616.00
13th May 2019YMAB - Y-mAbs Therapeutics, Inc.6,000Open or private sale934,000$20.61$123,647.40$19,247,778.60
28th May 2019YMAB - Y-mAbs Therapeutics, Inc.6,000Open or private sale928,000$20.21$121,252.20$18,753,673.60
3rd June 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale924,000$20.03$80,121.20$18,507,997.20
10th June 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale920,000$22.79$91,166.40$20,968,272.00
24th June 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale916,000$21.77$87,097.60$19,945,350.40
8th July 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale912,000$22.40$89,591.60$20,426,884.80
22nd July 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale908,000$22.54$90,176.80$20,470,133.60
5th August 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale904,000$21.78$87,105.60$19,685,865.60
19th August 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale900,000$27.70$110,804.80$24,931,080.00
3rd September 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale896,000$25.77$103,080.80$23,090,099.20
16th September 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale892,000$30.59$122,375.60$27,289,758.80
14th September 2020YMAB - Y-mAbs Therapeutics, Inc.22,569Open or private sale0$41.00$925,426.05$0.00
14th September 2020YMAB - Y-mAbs Therapeutics, Inc.22,569Exercise of derivative22,569$2.00$45,138.00$45,138.00
11th September 2020YMAB - Y-mAbs Therapeutics, Inc.13,571Open or private sale0$40.33$547,330.64$0.00
11th September 2020YMAB - Y-mAbs Therapeutics, Inc.13,571Exercise of derivative13,571$2.00$27,142.00$27,142.00
10th September 2020YMAB - Y-mAbs Therapeutics, Inc.13,860Open or private sale0$41.58$576,359.78$0.00
10th September 2020YMAB - Y-mAbs Therapeutics, Inc.13,860Exercise of derivative13,860$2.00$27,720.00$27,720.00
7th October 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale888,000$25.21$100,848.00$22,388,256.00
21st October 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale884,000$27.59$110,350.80$24,387,526.80
4th November 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale880,000$30.10$120,418.00$26,491,960.00
18th November 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale876,000$28.41$113,657.60$24,891,014.40
2nd December 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale872,000$32.48$129,930.40$28,324,827.20
16th December 2019YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale860,000$31.54$126,176.40$27,127,926.00
13th December 2019YMAB - Y-mAbs Therapeutics, Inc.8,000Bona fide gift864,000$0.00
30th December 2019YMAB - Y-mAbs Therapeutics, Inc.201Other acquisition or disposition1,030,356$0.00
13th January 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale856,000$30.90$123,612.00$26,452,968.00
27th January 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale852,000$35.06$140,223.60$29,867,626.80
10th February 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale848,000$33.03$132,120.80$28,009,609.60
18th February 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale844,000$32.78$131,132.80$27,669,020.80
2nd March 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale840,000$29.18$116,713.20$24,509,772.00
16th March 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale836,000$18.01$72,040.80$15,056,527.20
13th April 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale832,000$29.43$117,711.20$24,483,929.60
1st May 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale828,000$32.35$129,404.40$26,786,710.80
12th May 2020YMAB - Y-mAbs Therapeutics, Inc.50,000Open or private sale778,000$39.04$1,951,935.00$30,372,108.60
18th May 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale774,000$39.65$158,596.00$30,688,326.00
27th May 2020YMAB - Y-mAbs Therapeutics, Inc.50,000Open or private sale724,000$39.01$1,950,460.00$28,242,660.80
4th June 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale720,000$41.61$166,443.60$29,959,848.00
15th June 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale716,000$43.45$173,811.20$31,112,204.80
1st July 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale712,000$42.04$168,178.00$29,935,684.00
15th July 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale708,000$40.06$160,229.20$28,360,568.40
3rd August 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale704,000$36.51$146,026.00$25,700,576.00
12th August 2020YMAB - Y-mAbs Therapeutics, Inc.13,000Open or private sale654,000$39.51$513,636.50$25,839,867.00
11th August 2020YMAB - Y-mAbs Therapeutics, Inc.37,000Open or private sale667,000$40.06$1,482,042.40$26,716,818.40
17th August 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale650,000$40.35$161,392.00$26,226,200.00
1st September 2020YMAB - Y-mAbs Therapeutics, Inc.4,000Open or private sale646,000$41.60$166,390.40$26,872,049.60